155 results
Page 2 of 8
424B5
kg354i1w0pq1
20 Oct 22
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
qfpsptm
19 Sep 22
Other Events
8:00am
8-K
EX-99.2
g9b1ba
19 Sep 22
Other Events
8:00am
8-K
EX-10.1
womv1sbln7s407f88g
10 Aug 22
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-99.2
grqtzkx
25 Mar 22
Regulation FD Disclosure
8:40am
8-K
EX-99.1
rfa0ruk
25 Mar 22
Regulation FD Disclosure
8:40am
8-K
EX-10.1
kpe5y85vv6elxgs7t
25 May 21
Entry into a Material Definitive Agreement
9:04am
8-K
EX-99.1
539qm9f6s f5
13 May 21
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
8:25am
8-K
EX-99.1
p6ecsn9ijfjlgl
13 May 21
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
8:25am